| Reported | Recall | Class | Product | Firm |
|---|
| 2023-12-27 | D-0151-2024 | Class I | TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray… | Insight Pharmaceuticals Corporation |
| 2023-12-27 | D-0152-2024 | Class II | Selenium Sulfide 2 | Private Label Partners, Inc. |
| 2023-12-27 | D-0153-2024 | Class I | Phenytoin Oral Suspension | The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories |
| 2023-12-27 | D-0154-2024 | Class II | NYSTATIN 5BU | Fagron, Inc |
| 2023-12-27 | D-0155-2024 | Class II | NYSTATIN 500 MU | Fagron, Inc |
| 2023-12-27 | D-0156-2024 | Class II | NYSTATIN 2 BU | Fagron, Inc |
| 2023-12-27 | D-0157-2024 | Class II | NYSTATIN 150 MU | Fagron, Inc |
| 2023-12-27 | D-0158-2024 | Class I | THE ROCK | Noah's Wholesale LLC |
| 2023-12-27 | D-0159-2024 | Class I | Odor-Eaters Spray Powder | Blistex Inc |
| 2023-12-20 | D-0148-2024 | Class II | Penicillamine Tablets USP 250 mg | Lupin Pharmaceuticals Inc. |
| 2023-12-20 | D-0149-2024 | Class III | Votrient | Siegfried Barbera, SL |
| 2023-12-20 | D-0150-2024 | Class II | Liothyronine Sodium Tablets | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-12-13 | D-0137-2024 | Class III | buPROPion Hydrochloride Extended-Release Tablets | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-12-13 | D-0138-2024 | Class I | Dr | SUGARMDS LLC |
| 2023-12-13 | D-0139-2024 | Class II | Trospium Chloride Extended-Release Capsules | Padagis US LLC |
| 2023-12-13 | D-0140-2024 | Class III | LET Gel | Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop |
| 2023-12-13 | D-0141-2024 | Class II | ceFAZolin sodium in Sterile Water for injection | Wells Pharma of Houston LLC |
| 2023-12-13 | D-0142-2024 | Class II | KinderMed KIDS' PAIN & FEVER Acetaminophen | KINDER FARMS LLC |
| 2023-12-13 | D-0143-2024 | Class II | KinderMed INFANTS' PAIN & FEVER Acetaminophen | KINDER FARMS LLC |
| 2023-12-13 | D-0144-2024 | Class I | SANDIMMUNE Oral Solution | Novartis Pharmaceuticals Corporation |
| 2023-12-13 | D-0146-2024 | Class II | Ondansetron Injection | Baxter Healthcare Corporation |
| 2023-12-13 | D-0147-2024 | Class II | ROPivacaine HCl 0 | STAQ Pharma, Inc. |
| 2023-12-06 | D-0119-2024 | Class II | Paroxetine Hydrochloride Tablets USP | Apotex Corp. |
| 2023-12-06 | D-0120-2024 | Class II | Paroxetine Hydrochloride Tablets USP | Apotex Corp. |
| 2023-12-06 | D-0121-2024 | Class II | Paroxetine Hydrochloride Tablets USP | Apotex Corp. |
| 2023-12-06 | D-0122-2024 | Class II | Paroxetine Hydrochloride Tablets USP | Apotex Corp. |
| 2023-12-06 | D-0123-2024 | Class II | Indomethacin 25mg Capsules | Glenmark Pharmaceuticals Inc., USA |
| 2023-12-06 | D-0124-2024 | Class II | Naproxen Tablets | Glenmark Pharmaceuticals Inc., USA |
| 2023-12-06 | D-0125-2024 | Class III | Tropicamide 1% | Fagron Compounding Services |
| 2023-12-06 | D-0126-2024 | Class III | Aminocaproic Acid Oral Solution | VistaPharm LLC |
| 2023-12-06 | D-0127-2024 | Class III | Testosterone Gel | Teva Pharmaceuticals USA, Inc |
| 2023-12-06 | D-0128-2024 | Class II | PAROXETINE tablets | Golden State Medical Supply Inc. |
| 2023-12-06 | D-0129-2024 | Class II | PAROXETINE tablets | Golden State Medical Supply Inc. |
| 2023-12-06 | D-0130-2024 | Class II | PAROXETINE tablets | Golden State Medical Supply Inc. |
| 2023-12-06 | D-0145-2024 | Class I | VITRAKVI | Bayer Healthcare Pharmaceuticals Inc. |
| 2023-12-06 | D-0224-2024 | Class I | Artri King Reforzado con Origa y Omega 3 tablets | Botanical Be |
| 2023-12-06 | D-0225-2024 | Class I | Reumo Flex caplets | Botanical Be |
| 2023-12-06 | D-0226-2024 | Class I | Kuka Flex Forte caplets | Botanical Be |
| 2023-11-29 | D-0107-2024 | Class I | Polyvinyl Alcohol 1 | The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories |
| 2023-11-29 | D-0108-2024 | Class I | Lubricating Tears Eye Drops | The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories |
| 2023-11-29 | D-0109-2024 | Class II | Integrity Biochem HSC 70-LM | Integrity Bio-Chemicals LLC |
| 2023-11-29 | D-0110-2024 | Class II | Integrity Biochem HSC70-LV | Integrity Bio-Chemicals LLC |
| 2023-11-29 | D-0111-2024 | Class II | Integrity Biochem HSC 70-VA | Integrity Bio-Chemicals LLC |
| 2023-11-29 | D-0112-2024 | Class III | Esomeprazole Magnesium Delayed-Release Capsules | Glenmark Pharmaceuticals Inc., USA |
| 2023-11-29 | D-0113-2024 | Class III | Buspirone Hydrochloride Tabs USP 10 mg | NCS Healthcare of Kentucky Inc |
| 2023-11-29 | D-0114-2024 | Class III | Lisinopril Tablets USP 20 mg | NCS Healthcare of Kentucky Inc |
| 2023-11-29 | D-0115-2024 | Class II | Tiglutik | ITF PHARMA INC |
| 2023-11-29 | D-0116-2024 | Class I | 8 | Exela Pharma Sciences LLC |
| 2023-11-29 | D-0117-2024 | Class I | Midazolam in 0 | Exela Pharma Sciences LLC |
| 2023-11-29 | D-0118-2024 | Class I | ELCYS | Exela Pharma Sciences LLC |
| 2023-11-29 | D-0131-2024 | Class I | LEADER brand Eye Irritation Relief | Cardinal Health Inc. |
| 2023-11-29 | D-0132-2024 | Class I | LEADER brand Dry Eye Relief | Cardinal Health Inc. |
| 2023-11-29 | D-0133-2024 | Class I | LEADER brand Lubricant Eye Drops | Cardinal Health Inc. |
| 2023-11-29 | D-0134-2024 | Class I | LEADER brand Lubricant Eye Drops | Cardinal Health Inc. |
| 2023-11-29 | D-0135-2024 | Class I | LEADER brand Dry Eye Relief | Cardinal Health Inc. |
| 2023-11-29 | D-0136-2024 | Class I | LEADER brand Lubricant Eye Drops | Cardinal Health Inc. |
| 2023-11-22 | D-0103-2024 | Class II | DOP Instant Hand Sanitizer | Omega & Delta Co., Inc. |
| 2023-11-22 | D-0104-2024 | Class II | DOP Instant Hand Sanitizer | Omega & Delta Co., Inc. |
| 2023-11-22 | D-0105-2024 | Class II | Equate Hand Sanitizer | Omega & Delta Co., Inc. |
| 2023-11-22 | D-0106-2024 | Class II | Oxygen | Family Medical Supply Inc |
| 2023-11-15 | D-0086-2024 | Class II | Montelukast Sodium Tablets | Dr. Reddy's Laboratories, Inc. |
| 2023-11-15 | D-0087-2024 | Class II | Buprenorphine HCl | PAR Sterile Products LLC |
| 2023-11-15 | D-0088-2024 | Class III | Synthroid | AbbVie Inc. |
| 2023-11-15 | D-0089-2024 | Class III | Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP | Taro Pharmaceuticals Inc. |
| 2023-11-15 | D-0090-2024 | Class II | Extended Phenytoin Sodium Capsules | Amneal Pharmaceuticals of New York, LLC |
| 2023-11-15 | D-0091-2024 | Class II | Clinical TREAT Antifungal Powder | MEDLINE INDUSTRIES, LP - Northfield |
| 2023-11-15 | D-0092-2024 | Class II | Ranolazine Extended-Release Tablets 500mg | Glenmark Pharmaceuticals Inc., USA |
| 2023-11-15 | D-0093-2024 | Class III | Mycophenolate Mofetil for Oral Suspension | VistaPharm LLC |
| 2023-11-15 | D-0094-2024 | Class III | Oxaydo | Zyla Life Sciences US Inc. |
| 2023-11-15 | D-0095-2024 | Class II | Deferasirox Tablets for Oral Suspension | Glenmark Pharmaceuticals Inc., USA |
| 2023-11-15 | D-0096-2024 | Class II | Oxybutynin Chloride Extended-Release Tablet USP | Zydus Pharmaceuticals (USA) Inc |
| 2023-11-15 | D-0097-2024 | Class II | Oxybutynin Chloride Extended-Release Tablet USP | Zydus Pharmaceuticals (USA) Inc |
| 2023-11-15 | D-0098-2024 | Class II | Oxybutynin Chloride Extended-Release Tablet USP | Zydus Pharmaceuticals (USA) Inc |
| 2023-11-15 | D-0099-2024 | Class III | V-FORCE Homeopathic | Grato Holdings, Inc. |
| 2023-11-15 | D-0100-2024 | Class I | 4 | Pfizer Inc. |
| 2023-11-15 | D-0101-2024 | Class I | 1% Lidocaine HCl Injection | Pfizer Inc. |
| 2023-11-15 | D-0102-2024 | Class I | 2% Lidocaine HCl Injection | Pfizer Inc. |
| 2023-11-08 | D-0073-2024 | Class II | TUMS Antacid | GlaxoSmithKline Consumer Healthcare Holdings LLC |
| 2023-11-08 | D-0074-2024 | Class II | TUMS Antacid | GlaxoSmithKline Consumer Healthcare Holdings LLC |
| 2023-11-08 | D-0075-2024 | Class II | TUMS Antacid | GlaxoSmithKline Consumer Healthcare Holdings LLC |
| 2023-11-08 | D-0076-2024 | Class II | TUMS Antacid | GlaxoSmithKline Consumer Healthcare Holdings LLC |
| 2023-11-08 | D-0077-2024 | Class II | TUMS Antacid | GlaxoSmithKline Consumer Healthcare Holdings LLC |
| 2023-11-08 | D-0078-2024 | Class II | TUMS Antacid | GlaxoSmithKline Consumer Healthcare Holdings LLC |
| 2023-11-08 | D-0079-2024 | Class II | TUMS Antacid | GlaxoSmithKline Consumer Healthcare Holdings LLC |
| 2023-11-08 | D-0080-2024 | Class III | Opium Tincture | Edenbridge Pharmaceuticals, LLC |
| 2023-11-08 | D-0081-2024 | Class II | Gynazole-1 | Padagis US LLC |
| 2023-11-08 | D-0082-2024 | Class II | Strong Iodine Solution U | Safecor Health, LLC |
| 2023-11-08 | D-0083-2024 | Class II | Liothyronine Sodium Tablets | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-11-08 | D-0084-2024 | Class II | Liothyronine Sodium Tablets | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-11-08 | D-0085-2024 | Class III | Bisoprolol Fumarate and Hydrochlorothiazide Tablets | Glenmark Pharmaceuticals Inc., USA |
| 2023-11-01 | D-0066-2024 | Class III | Methotrexate Tablets | West-Ward Columbus Inc |
| 2023-11-01 | D-0067-2024 | Class I | ION*Sinus Spray | Biomic Sciences, LLC dba ION Intelligence of Nature |
| 2023-11-01 | D-0068-2024 | Class II | ION* Sinus Support Nasal Spray | Biomic Sciences, LLC dba ION Intelligence of Nature |
| 2023-11-01 | D-0069-2024 | Class II | Restore Sinus Spray | Biomic Sciences, LLC dba ION Intelligence of Nature |
| 2023-11-01 | D-0070-2024 | Class III | Oxytocin synthetic | Denver Solutions, LLC DBA Leiters Health |
| 2023-11-01 | D-0071-2024 | Class III | VANCOmycin HCI PF | Denver Solutions, LLC DBA Leiters Health |
| 2023-11-01 | D-0072-2024 | Class III | VANCOmycin HCI PF | Denver Solutions, LLC DBA Leiters Health |
| 2023-10-25 | D-0043-2024 | Class III | MYDRIATIC-4: Tropicamide | Imprimis NJOF, LLC |
| 2023-10-25 | D-0044-2024 | Class III | Bupropion Hydrochloride Extended-Release Tablets USP | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-10-25 | D-0045-2024 | Class II | Certain Over-The-Counter | Dollar Tree Distribution, Inc. |
| 2023-10-25 | D-0046-2024 | Class I | TheraBreath for Kids! Oral Rinse | Church & Dwight Inc |
| 2023-10-25 | D-0047-2024 | Class I | Sucralfate Oral Suspension | VistaPharm LLC |
| 2023-10-25 | D-0048-2024 | Class II | Doxil | Baxter Healthcare Corporation |
| 2023-10-25 | D-0049-2024 | Class I | Betaxolol Tablets | KVK-Tech, Inc. |
| 2023-10-25 | D-0050-2024 | Class II | Bevacizumab 1 | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0051-2024 | Class II | Vancomycin 1 MG/0 | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0052-2024 | Class II | Endophth Kit | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0053-2024 | Class II | Calcium Gluconate Ophthalmic Irrigation Solution 1% | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0054-2024 | Class II | Calcium Gluconate 2 | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0055-2024 | Class II | Tropi-Phen | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0056-2024 | Class II | Moxifloxacin in Balanced Salt Solution | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0057-2024 | Class II | Cefuroxime 4mg /0 | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0058-2024 | Class II | Moxifloxacin in Balanced Salt Solution 400 mcg/0 | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0059-2024 | Class II | Lidocaine-phenylephrine 1%-1 | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0060-2024 | Class II | TPC Drops | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0061-2024 | Class II | Calcium chloride Solution for Intravenous Injection | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0062-2024 | Class II | Lidocaine HCl 4% ophthalmic solution | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0063-2024 | Class II | Tropi-Phen | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0064-2024 | Class II | Lidocaine HCL 2% and Oxymetazoline HCl 0 | Pine Pharmaceuticals, LLC |
| 2023-10-25 | D-0065-2024 | Class II | Foscarnet Sodium 2 | Pine Pharmaceuticals, LLC |
| 2023-10-18 | D-0042-2024 | Class I | BREXAFEMME | Scynexis, Inc. |
| 2023-10-11 | D-0001-2024 | Class II | fentaNYL in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0002-2024 | Class II | ketamine in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0003-2024 | Class II | ePHEDrine in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0004-2024 | Class II | lidocaine 2% | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0005-2024 | Class II | PHENYLephrine in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0006-2024 | Class II | PHENYLephrine in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0007-2024 | Class II | PHENYLephrine in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0008-2024 | Class II | rocuronium | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0009-2024 | Class II | fentaNYL in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0010-2024 | Class II | fentaNYL in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0011-2024 | Class II | fentaNYL in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0012-2024 | Class II | fentaNYL in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0013-2024 | Class II | fentaNYL in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0014-2024 | Class II | fentaNYL in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0015-2024 | Class II | fentaNYL 1 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0016-2024 | Class II | fentaNYL 2 mcg/mL and bupivacaine 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0017-2024 | Class II | fentaNYL 2 mcg/mL and bupivacaine 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0018-2024 | Class II | midazolam in dextrose 5% | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0019-2024 | Class II | fentaNYL | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0020-2024 | Class II | fentaNYL | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0021-2024 | Class II | fentaNYL | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0022-2024 | Class II | fentaNYL | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0023-2024 | Class II | fentaNYL | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0024-2024 | Class II | fentaNYL in dextrose 5% | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0025-2024 | Class II | fentaNYL | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0026-2024 | Class II | succinylcholine | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0027-2024 | Class II | HYDROmorphone in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0028-2024 | Class II | HYDROmorphone in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0029-2024 | Class II | HYDROmorphone in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0030-2024 | Class II | HYDROmorphone in dextrose 5% | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0031-2024 | Class II | HYDROmorphone in 0 | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0032-2024 | Class II | HYDROmorphone in dextrose 5% | Central Admixture Pharmacy Services Inc |
| 2023-10-11 | D-0033-2024 | Class II | Dr | Dr. Berne's Whole Health Products |
| 2023-10-11 | D-0034-2024 | Class II | Dr | Dr. Berne's Whole Health Products |
| 2023-10-11 | D-0035-2024 | Class II | Dr | Dr. Berne's Whole Health Products |
| 2023-10-11 | D-0036-2024 | Class II | Dr | Dr. Berne's Whole Health Products |
| 2023-10-11 | D-0037-2024 | Class I | Dr | Dr. Berne's Whole Health Products |
| 2023-10-11 | D-0038-2024 | Class II | Oxybutynin Chloride Extended-Release Tablets USP 10 mg | Zydus Pharmaceuticals (USA) Inc |
| 2023-10-11 | D-0039-2024 | Class III | HydrALAZINE Hydrochloride Tablets | Amerisource Health Services LLC |
| 2023-10-11 | D-0040-2024 | Class III | Epinephrine-Lidocaine HCl | Imprimis NJOF, LLC |
| 2023-10-11 | D-0041-2024 | Class II | Triamcinolone Acetonide Injectable Suspension | Eugia US LLC |
| 2023-10-04 | D-1177-2023 | Class II | Florbetaben F-18 | Sofie Co dba Sofie |
| 2023-10-04 | D-1178-2023 | Class III | Eligard | Tolmar, Inc. |
| 2023-10-04 | D-1179-2023 | Class III | Clearasil Rapid Rescue Deep Treatment Pads | RB Health (US) LLC |
| 2023-09-27 | D-1151-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1152-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1153-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1154-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1155-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1156-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1157-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1158-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1159-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1160-2023 | Class II | MAJOR LubriFresh P | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1161-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1162-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1163-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1164-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1165-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1166-2023 | Class II | TRP Natural Eyes | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1167-2023 | Class II | octiq Lubricating Eye Drops | AMMAN PHARMACEUTICAL INDUSTRIES |
| 2023-09-27 | D-1168-2023 | Class II | BD ChloraPrep Clear | CareFusion 213, LLC |
| 2023-09-27 | D-1171-2023 | Class II | Rasagiline Tablets 0 | Aurobindo Pharma USA Inc. |
| 2023-09-27 | D-1172-2023 | Class III | Cequa | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-09-27 | D-1173-2023 | Class III | Kroger Mint Burst ANTISEPTIC MOUTH RINSE ANTIGINGIVITIS/ANTIPLAQUE | Vi-Jon, LLC |
| 2023-09-27 | D-1174-2023 | Class I | SANDIMMUNE Oral Solution | Novartis Pharmaceuticals Corp. |
| 2023-09-27 | D-1175-2023 | Class II | Humanrace Suncare | HUMANRACE |
| 2023-09-27 | D-1176-2023 | Class II | Humanrace Suncare | HUMANRACE |
| 2023-09-20 | D-1148-2023 | Class II | Pantoprazole Sodium for Injection 40mg per vial | BE PHARMACEUTICALS AG |
| 2023-09-20 | D-1149-2023 | Class II | Sucralfate Oral Suspension 1g per 10mL | VistaPharm LLC |
| 2023-09-20 | D-1180-2023 | Class I | WEFUN Capsules 825 mg | Hua Da Trading, Inc. dba Wefun Inc. |
| 2023-09-13 | D-1143-2023 | Class III | Nexlizet | Esperion |
| 2023-09-13 | D-1144-2023 | Class III | Milrinone Lactate Injection | Caplin Steriles Limited |
| 2023-09-13 | D-1145-2023 | Class III | Fosfomycin Tromethamine Granules for Oral Solution | Ascend Laboratories, LLC |
| 2023-09-13 | D-1146-2023 | Class II | Sodium Fluoride 1 | AVKARE LLC |
| 2023-09-13 | D-1147-2023 | Class II | Capsaicin Cream 0 | AVKARE LLC |
| 2023-09-13 | D-1169-2023 | Class I | Digoxin Tablets | Marlex Pharmaceuticals, Inc. |
| 2023-09-13 | D-1170-2023 | Class II | Digoxin Tablets | Marlex Pharmaceuticals, Inc. |
| 2023-09-06 | D-1107-2023 | Class II | CARDIOPLEGIA SOLUTION | Central Admixture Pharmacy Services, Inc. |